SYSTEMATIC FINANCIAL MANAGEMENT LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
SYSTEMATIC FINANCIAL MANAGEMENT LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2018$1,000
-100.0%
39
-100.0%
0.00%
-100.0%
Q3 2018$11,844,000
+12.3%
194,290
-10.1%
0.29%
+10.9%
Q2 2018$10,547,000
-37.5%
215,999
+36.1%
0.26%
-30.8%
Q1 2018$16,864,000
-17.0%
158,707
-53.4%
0.37%
-8.1%
Q4 2017$20,329,000
+13.6%
340,403
-54.4%
0.41%
+11.8%
Q3 2017$17,903,000
+24.9%
745,979
+1.8%
0.36%
+37.0%
Q2 2017$14,331,000
-16.0%
733,030
+0.9%
0.26%
-12.3%
Q1 2017$17,055,000
+86.5%
726,653
-2.5%
0.30%
+108.3%
Q4 2016$9,144,000
-21.0%
745,229
+10.6%
0.14%
-10.5%
Q3 2016$11,571,000
-2.6%
673,520
-19.3%
0.16%0.0%
Q2 2016$11,876,000
+0.3%
834,589
-3.1%
0.16%
+9.5%
Q1 2016$11,838,000
-20.7%
860,991
-2.8%
0.15%
-9.2%
Q4 2015$14,919,000
+29.5%
885,417
-15.8%
0.16%
+33.6%
Q3 2015$11,523,000
-18.1%
1,051,447
-6.5%
0.12%
+1.7%
Q2 2015$14,068,000
+17.4%
1,124,589
+3.3%
0.12%
+26.3%
Q1 2015$11,979,000
-29.2%
1,089,075
-0.3%
0.10%
-24.0%
Q4 2014$16,923,000
+14.2%
1,091,833
-11.1%
0.12%
+15.7%
Q3 2014$14,816,000
-17.2%
1,227,587
-12.1%
0.11%
-11.5%
Q2 2014$17,899,000
+9.0%
1,396,249
+3.0%
0.12%
+8.0%
Q1 2014$16,423,000
-11.7%
1,355,059
-17.3%
0.11%
-16.9%
Q4 2013$18,607,000
+6.6%
1,639,423
-1.9%
0.14%
-1.4%
Q3 2013$17,462,000
+5.0%
1,671,887
+16.1%
0.14%
-3.5%
Q2 2013$16,632,0001,440,0780.14%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders